Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
The latest update is out from Oragenics Inc (OGEN).
Oragenics, Inc. successfully executed an underwriting agreement to sell 1.4 million shares at $1.50 each, raising $2.1 million before expenses, with options for over-allotment and additional warrants. The underwriters purchased shares at a slightly lower price and received warrants exercisable at $1.875. This strategic financial move, which closed on March 1, 2024, aims to strengthen the company’s financial position, with the details filed with the SEC and shared in a press release to keep investors informed.
For a thorough assessment of OGEN stock, go to TipRanks’ Stock Analysis page.
